Corewell Health Ends Gender-Affirming Care for Minors in Michigan Amid Federal Pressure

Corewell Health has announced it will no longer provide puberty blockers or hormone therapy to minors for gender affirmation due to the serious risk of legal and regulatory action amid pressure from President Donald Trump's administration. This decision follows a similar move by Michigan Medicine, which ceased gender-affirming care for patients under 19 after being subpoenaed in a federal investigation. Corewell emphasized it will continue to offer mental health support and psychosocial services to patients in transition, while noting the need to protect both healthcare providers and patients. Advocacy groups have expressed concern over the harms to transgender youth, citing medical organizations that recognize gender-affirming care as evidence-based and necessary for mental health improvements. These developments come after Trump signed an executive order targeting hospitals that provide such care to minors, threatening to cut federal funding. Corewell previously paused and then resumed gender-affirming care earlier in 2025 but has now reversed course amid escalating legal threats.